FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Lisdexamfetamine Dimesylate Capsule

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-lisdexamfetamine-dimesylate-capsule-apotex-corp-60505-4741-1

Drug Shortage Details

Generic NameLisdexamfetamine Dimesylate Capsule
Manufacturer / CompanyApotex Corp.
Therapeutic CategoryPsychiatry
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code60505-4741-1
Presentation & Dosage Form

Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)

Manufacturer Contact Info

800-706-5575


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.